Src Kinase Inhibitors
| Cat. No. | Product Name / Activity |
|---|---|
| 3914 | A 419259 trihydrochloride |
| Inhibitor of Src family kinases | |
| 6400 | Alsterpaullone |
| Lck inhibitor; also inhibits CDK1/2 and GSK-3β | |
| 3963 | AZM 475271 |
| Src tyrosine kinase inhibitor | |
| 4361 | Bosutinib |
| Dual Src-Abl inhibitor; antiproliferative | |
| 1936 | Damnacanthal |
| Potent, selective p56lck inhibitor; also LIMK1/2 inhibitor | |
| 6793 | Dasatinib |
| Highly potent pan-Src/Bcr-Abl inhibitor | |
| 1629 | Herbimycin A |
| Src family kinase inhibitor. Also Hsp90 inhibitor | |
| 4660 | KB SRC 4 |
| Potent and selective c-Src inhibitor | |
| 1331 | Lavendustin A |
| EGFR, p60c-src inhibitor | |
| 5592 | LCB 03-0110 dihydrochloride |
| Potent c-SRC kinase inhibitor; also inhibits DDR2, BTK and Syk | |
| 2265 | Lyn peptide inhibitor |
| Inhibits Lyn activation via hematopoietin βc receptor; cell-permeable | |
| 2877 | MNS |
| Selective inhibitor of Src and Syk | |
| 3063 | 1-Naphthyl PP1 |
| Src family kinase inhibitor; also inhibits c-Abl | |
| 6073 | P21d hydrochloride |
| Potent and selective Brk inhibitor | |
| 3785 | PD 166285 dihydrochloride |
| Potent Src inhibitor; also inhibits FGFR1, PDGFRβ and Wee1 | |
| 4965 | PD 180970 |
| p210Bcr/Abl kinase inhibitor; also inhibits c-Src and KIT | |
| 1554 | Piceatannol |
| p56lck and Syk kinase inhibitor | |
| 1397 | PP 1 |
| Potent, selective Src family kinase inhibitor | |
| 1407 | PP 2 |
| Potent, selective Src family kinase inhibitor | |
| 2794 | PP 3 |
| Negative control for PP 2 (Cat. No. 1407) | |
| 1923 | pp60 c-src (521-533) (phosphorylated) |
| Inhibits tyrosine kinase activity of pp60c-src and pp60v-src | |
| 3642 | Src I1 |
| Dual site Src kinase inhibitor | |
| 6475 | SU 6656 |
| Potent ATP-competitive Src family kinase inhibitor; also AMPK inhibitor; cell permeable | |
| 3567 | TC-S 7003 |
| Potent Lck inhibitor | |
| 5579 | Tilfrinib |
| Potent and selective breast tumor kinase (Brk) inhibitor | |
| 6981 | TL 0259 New |
| Selective and highly potent Fgr and Lyn kinase inhibitor; orally bioavailable | |
| 5413 | WH-4-023 |
| Potent and selective Lck and Src inhibitor; also inhibits SIK |
Cancer Research Product Guide
Our Cancer Research Guide highlights over 750 products for cancer research.
Request copyDownload PDFImmunology Guide
Our Immunology listing highlights over 190 products for immunology research.
Request copyDownload PDFKinases Product Listing
Our Kinase listing highlights over 400 products for kinase research.
Request copyDownload PDF